LabConnect and Bostwick Scientific Launch Centralized Anatomic Pathology Testing Service
Clinical and Anatomic Central Laboratory Services Combined
SEATTLE, WA-April 4, 2008-Central laboratory services provider LabConnect, announced today that it has signed Bostwick Scientific, the clinical trials division of Bostwick Laboratories, the world’s largest provider of centralized anatomic pathology testing services for clinical trials, as an exclusive provider.
The combination of Bostwick Scientific and LabConnect provide clinical trial sponsors with one source for key opinion leaders in anatomic pathology and central laboratory experts and combine the country’s fastest growing anatomic pathology lab and central lab. Bostwick Laboratories was formed in 1999 by David G. Bostwick, MD, MBA an internationally renowned expert in urologic pathology. Bostwick Laboratories operates six facilities in the U.S. and Europe and provides histological and cytological diagnosis in human pathology with special expertise in urogenital, gastrointestinal, gynecological, dermatologic and hematologic pathology. Bostwick Scientific has processed more than 35,000 clinical trial cases to date.
“We’re in the early stages of the evolution of anatomic pathology testing in clinical trials,” noted Eric Hayashi, LabConnect president and chief executive officer. “Sponsors are increasingly realizing the benefits of the centralization of their anatomic pathology testing needs just as they have realized similar benefits in centralizing routine and specialized clinical pathology.”
About LabConnect, LLC
LabConnect ( www.labconnectllc.com ), established in 2002, is a leading provider of central laboratory services to the biopharmaceutical industry. LabConnect’s global network of world-class laboratories provide an extensive menu of clinical trial testing services and have supported hundreds of clinical trials ranging from small single-site to large global studies with complex testing and logistical requirements.
About Bostwick Laboratories
Bostwick Laboratories ( www.bostwicklaboratories.com ) is a specialized anatomic pathology laboratory focused on the diagnosis of cancer. Bostwick Laboratories is a leader in urologic anatomic pathology, with expertise and a growing presence in the nephrology, gynecology, gastroenterology, and hematology sectors of the anatomic pathology market. Bostwick Laboratories is headquartered in Glen Allen, VA, and operates six laboratories located in VA, AZ, NY, FL, TN, and London, UK.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
